|
Name |
[(7S,8S)-7-hydroxy-7-methyl-6-oxo-3-[(E)-prop-1-enyl]-8H-isochromen-8-yl] 2,4-dihydroxy-6-methylbenzoate
|
Molecular Formula | C21H20O7 | |
IUPAC Name* |
[(7S,8S)-7-hydroxy-7-methyl-6-oxo-3-[(E)-prop-1-enyl]-8H-isochromen-8-yl] 2,4-dihydroxy-6-methylbenzoate
|
|
SMILES |
C/C=C/C1=CC2=CC(=O)[C@@]([C@H](C2=CO1)OC(=O)C3=C(C=C(C=C3C)O)O)(C)O
|
|
InChI |
InChI=1S/C21H20O7/c1-4-5-14-7-12-8-17(24)21(3,26)19(15(12)10-27-14)28-20(25)18-11(2)6-13(22)9-16(18)23/h4-10,19,22-23,26H,1-3H3/b5-4+/t19-,21+/m0/s1
|
|
InChIKey |
SYFXCPIQIAFGIJ-PXODQFSGSA-N
|
|
Synonyms |
CHEMBL3593566; Sch-1385568; BDBM50104724
|
|
CAS | NA | |
PubChem CID | 44225039 | |
ChEMBL ID | CHEMBL3593566 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.4 | ALogp: | 2.2 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 113.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 28 | QED Weighted: | 0.685 |
Caco-2 Permeability: | -5.053 | MDCK Permeability: | 0.00002030 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.174 |
Human Intestinal Absorption (HIA): | 0.347 | 20% Bioavailability (F20%): | 0.987 |
30% Bioavailability (F30%): | 0.883 |
Blood-Brain-Barrier Penetration (BBB): | 0.279 | Plasma Protein Binding (PPB): | 90.55% |
Volume Distribution (VD): | 1.246 | Fu: | 7.15% |
CYP1A2-inhibitor: | 0.97 | CYP1A2-substrate: | 0.364 |
CYP2C19-inhibitor: | 0.646 | CYP2C19-substrate: | 0.071 |
CYP2C9-inhibitor: | 0.77 | CYP2C9-substrate: | 0.798 |
CYP2D6-inhibitor: | 0.943 | CYP2D6-substrate: | 0.115 |
CYP3A4-inhibitor: | 0.88 | CYP3A4-substrate: | 0.253 |
Clearance (CL): | 4.779 | Half-life (T1/2): | 0.67 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.966 |
Drug-inuced Liver Injury (DILI): | 0.793 | AMES Toxicity: | 0.966 |
Rat Oral Acute Toxicity: | 0.976 | Maximum Recommended Daily Dose: | 0.964 |
Skin Sensitization: | 0.921 | Carcinogencity: | 0.922 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.741 |
Respiratory Toxicity: | 0.921 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002726 | 0.583 | D07MGA | 0.280 | ||||
ENC002798 | 0.560 | D04AIT | 0.252 | ||||
ENC003640 | 0.524 | D0K8KX | 0.248 | ||||
ENC002211 | 0.490 | D08NQZ | 0.231 | ||||
ENC003615 | 0.490 | D06GCK | 0.229 | ||||
ENC003837 | 0.481 | D0J2NK | 0.227 | ||||
ENC005503 | 0.476 | D0Q0PR | 0.226 | ||||
ENC002132 | 0.468 | D0Y7PG | 0.226 | ||||
ENC002131 | 0.435 | D0H2ZW | 0.223 | ||||
ENC003304 | 0.427 | D0H0SJ | 0.220 |